Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo

 

Unsupported browser: Your browser does not meet modern web standards. See how it scores »

The fat hormone leptin was once thought of as a potential obesity wonder drug, but the reality has proved more complex. Leptin is a signal released by fat cells that tells the brain when to stop eating, and initially it showed promise in treating obesity in mice. But now it is known that obese humans actually have high levels of leptin–their brains just become deaf to its signal. This condition, called leptin resistance, has proved trickier to understand and overcome.

A new study published in Cell Metabolism by Harvard Medical School researchers finds that leptin resistance may be a result of a traffic jam in the protein-making part of brain cells: a structure called endoplasmic reticulum (ER), where proteins are created, folded, and sent to other parts of the cell.

Lead author Umut Ozcan, a researcher at Children’s Hospital Boston, explains that cells become deaf to leptin when protein production goes awry–a condition called ER stress. “If there’s more demand than the ER can handle, proteins start to aggregate,” he says. Certain chemical signals can also slow down production, creating the same effect. ER stress leads the cell to release a series of chemical signals in an attempt to fix the situation–a process called the unfolded protein response–and if the condition becomes extreme, the cell may eventually die.

Ozcan had previously linked ER stress in certain body tissues to type 2 diabetes and insulin resistance, which led them to investigate whether the same condition could be tied to obesity. The team discovered that mice fed a high-fat diet showed signs of ER stress in the hypothalamus, the main region of the brain that receives signals from leptin. The researchers then deleted a protein in the hypothalamus of normal mice, which impaired ER function and made cells vulnerable to ER stress. “These mice became severely leptin resistant and started to become obese” when fed a high-fat diet, Ozcan says.

Furthermore, the researchers found that relieving ER stress in obese mice could help restore leptin signaling and alleviate obesity. They used two FDA-approved drugs that have been shown to counteract ER stress and are currently used to treat cystic fibrosis and neurodegenerative disease. These drugs, called PBA and TUDCA, are “chemical chaperones”: molecules that increase the ER’s capacity to fold proteins. Mice living on a high-fat diet were first treated with one of the chemical chaperones for 10 days, and then treated daily with leptin. This regimen led the mice to eat less and lose between 16 and 19 percent of their body weight, primarily as fat.

2 comments. Share your thoughts »

Credit: Umut Ozcan

Tagged: Biomedicine, Diabetes, protein, obesity, diet, weight loss, leptin

Reprints and Permissions | Send feedback to the editor

From the Archives

Close

Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me